Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Market Cap $246.7M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SMP | Ann: Annual General Meeting Webcast Instructions | 10:58 | 0 | 110 | |||
|
|||||||
SMP | Ann: Notice of Annual General Meeting Proxy Form | 10:58 | 0 | 105 | |||
|
|||||||
SMP | Ann: Notice of Annual General Meeting | 10:58 | 0 | 129 | |||
|
|||||||
SMP | Ann: Market update on debit card surcharging in Australia. | 15/07/25 | 62 | 26K | |||
|
|||||||
SMP | Ann: Scheme Implementation Agreement | 11/07/25 | 10 | 2.7K | |||
|
|||||||
SMP | Ann: Smartpay enters into Scheme Implementation Agreement | 23/06/25 | 0 | 449 | |||
|
|||||||
SMP | Ann: Director Nominations | 17/06/25 | 0 | 257 | |||
|
|||||||
SMP | Ann: FY25 Full Year Results Presentation | 10/06/25 | 10 | 3.2K | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |